Ballentine Partners’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $333K | Sell |
3,648
-140
| -4% | -$12.8K | 0.01% | 651 |
|
|
2025
Q1 | $429K | Sell |
3,788
-783
| -17% | -$88.6K | 0.01% | 494 |
|
|
2024
Q4 | $483K | Buy |
4,571
+716
| +19% | +$75.6K | 0.01% | 434 |
|
|
2024
Q3 | $416K | Buy |
3,855
+73
| +2% | +$7.88K | 0.01% | 473 |
|
|
2024
Q2 | $410K | Sell |
3,782
-175
| -4% | -$19K | 0.01% | 451 |
|
|
2024
Q1 | $522K | Buy |
3,957
+100
| +3% | +$13.2K | 0.01% | 378 |
|
|
2023
Q4 | $469K | Buy |
3,857
+41
| +1% | +$4.99K | 0.01% | 383 |
|
|
2023
Q3 | $428K | Sell |
3,816
-3
| -0.1% | -$337 | 0.01% | 347 |
|
|
2023
Q2 | $556K | Sell |
3,819
-320
| -8% | -$46.6K | 0.01% | 291 |
|
|
2023
Q1 | $535K | Buy |
4,139
+7
| +0.2% | +$904 | 0.01% | 288 |
|
|
2022
Q4 | $527K | Buy |
4,132
+2
| +0% | +$255 | 0.02% | 269 |
|
|
2022
Q3 | $432K | Buy |
4,130
+217
| +6% | +$22.7K | 0.01% | 270 |
|
|
2022
Q2 | $412K | Sell |
3,913
-103
| -3% | -$10.8K | 0.01% | 264 |
|
|
2022
Q1 | $513K | Buy |
4,016
+221
| +6% | +$28.2K | 0.02% | 253 |
|
|
2021
Q4 | $468K | Buy |
3,795
+58
| +2% | +$7.15K | 0.01% | 282 |
|
|
2021
Q3 | $531K | Buy |
3,737
+4
| +0.1% | +$568 | 0.02% | 228 |
|
|
2021
Q2 | $583K | Buy |
3,733
+1,215
| +48% | +$190K | 0.02% | 214 |
|
|
2021
Q1 | $391K | Sell |
2,518
-60
| -2% | -$9.32K | 0.01% | 260 |
|
|
2020
Q4 | $386K | Hold |
2,578
| – | – | 0.02% | 244 |
|
|
2020
Q3 | $340K | Buy |
2,578
+4
| +0.2% | +$528 | 0.02% | 271 |
|
|
2020
Q2 | $299K | Buy |
2,574
+28
| +1% | +$3.25K | 0.01% | 277 |
|
|
2020
Q1 | $251K | Sell |
2,546
-156
| -6% | -$15.4K | 0.01% | 279 |
|
|
2019
Q4 | $393K | Buy |
2,702
+34
| +1% | +$4.95K | 0.02% | 252 |
|
|
2019
Q3 | $355K | Buy |
2,668
+232
| +10% | +$30.9K | 0.02% | 258 |
|
|
2019
Q2 | $278K | Buy |
2,436
+202
| +9% | +$23.1K | 0.01% | 304 |
|
|
2019
Q1 | $277K | Sell |
2,234
-17
| -0.8% | -$2.11K | 0.01% | 256 |
|
|
2018
Q4 | $227K | Buy |
+2,251
| New | +$227K | 0.01% | 283 |
|